Thyrocare Technologies Limited

WhiteOak Capital Mutual Fund bought 641,000 shares of Thyrocare Technologies for ₹40.00 Cr at ₹624.00 apiece in a block deal on August 13, 2026.

A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.

Founded by Prashant Khemka, former CIO of Goldman Sachs Asset Management India. Manages over Rs 20,000 crore with a concentrated bottom-up approach rooted in fundamental quality research. WhiteOak's edge is the proprietary SQGLP (Scalability, Quality, Growth, Longevity, Price) framework applied with global research standards to Indian equities.